Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

Mr. Iwaaki  Taniguchi

Senior Vice President of Corporate Finance & Controlling Department

Mr. Christophe  Weber

President, Chief Executive Officer & Representative Director

Mr. Milano  Furuta

Chief Financial Officer

Mr. Christopher David  O'Reilly

Global Head of Investor Relations & Global Finance

Dr. Andrew S.  Plump

President of Research & Development and Representative Director

Dr. Seigo  Izumo

Chair of Management Board

Norimasa  Takeda

Chief Accounting Officer & Corporate Controller

Mr. Salvatore  Alesci M.D., Ph.D.

Member of Management Board and Head of R&D Global Science & Biomedical Policy

Mr. Haruhiko  Hirate

Member of Management Board

Mr. Gabriele  Ricci

Chief Data & Technology Officer

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited Štruktúra vedenia

Informácie o vedení